{
    "Trade/Device Name(s)": [
        "POGO Automatic Blood Glucose Monitoring System",
        "POGO\u00ae Automatic\u2122M Blood Glucose Monitoring System",
        "POGO\u00ae Control Solution",
        "POGO Automatic Test Cartridges"
    ],
    "Submitter Information": "Intuity Medical, Inc.",
    "510(k) Number": "K152493",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081389",
        "K123851"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "August 31, 2015",
    "Summary Letter Received Date": "September 2, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        "POGO Automatic Test Cartridge",
        "Individual, single use 25 uL HDPE wand inside foil pouch"
    ],
    "Instrument(s)/Platform(s)": [
        "POGO Automatic Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric (LED)",
        "Glucose oxidase enzyme",
        "Dry-reagent test strip",
        "Integrated lancing and sample collection"
    ],
    "Methodologies": [
        "Colorimetric measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Cartridge",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for POGO Automatic Blood Glucose Monitoring System with integrated lancing, sample collection, and photometric glucose quantitation for home use",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips by a single person with diabetes at home for monitoring diabetes control; not for diagnosis, screening, or neonatal use; indicated for adults and adolescents (13+).",
    "fda_folder": "Clinical Chemistry"
}